Joanna Sadowska, PhD, EMBA’s Post

View profile for Joanna Sadowska, PhD, EMBA, graphic

Scientist and Engineer | Executive MBA | Pharma and Biotech Market Research | Science Liaison | Technical Writer | Medical Communications

🧬 𝐆𝐞𝐧𝐞 𝐞𝐝𝐢𝐭𝐢𝐧𝐠 𝐬𝐭𝐚𝐫𝐭𝐞𝐝 𝐥𝐢𝐯𝐢𝐧𝐠 𝐢𝐭𝐬 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐢𝐧 2023 The developments in the gene editing and CRISPR space in 2023 point towards a future where such therapies could become more accessible and transformational for patients worldwide: ⚆ 2023 resulted in the first approval of CRISPR-based therapies, bringing new treatment technologies to the cell & gene therapies space ⚆ CRISPR 2.0 (a technology which can convert one base letter into another) and CRISPR 3.0 (a technology which replaces bits of DNA or inserts new chunks of genetic code) are on their way ⚆ Despite their transformational nature, cost and global accessibility remain major issues 𝘞𝘩𝘢𝘵 𝘤𝘩𝘢𝘯𝘨𝘦𝘴 𝘢𝘯𝘥 𝘤𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦𝘴 𝘤𝘢𝘯 𝘸𝘦 𝘦𝘹𝘱𝘦𝘤𝘵 𝘪𝘯 𝘵𝘩𝘦 𝘨𝘦𝘯𝘦 𝘦𝘥𝘪𝘵𝘪𝘯𝘨 𝘧𝘪𝘦𝘭𝘥 𝘪𝘯 2024? https://lnkd.in/eENnMkqi #crispr #geneediting #genetherapy #pharma #biotech #womeninscience #drjojo

Gene editing had a banner year in 2023

Gene editing had a banner year in 2023

technologyreview.com

To view or add a comment, sign in

Explore topics